T2 Biosystems Inc.

OTC: TTOO · Real-Time Price · USD
0.13
0.01 (8.79%)
At close: Apr 04, 2025, 3:42 PM

T2 Biosystems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.19M 22.3M 28.06M
Cost of Revenue
15.36M 21.14M 20.7M
Gross Profit
-8.17M 1.17M 7.36M
Operating Income
-49.66M -55.51M -42.97M
Interest Income
n/a 8K 112K
Pretax Income
-50.08M -62.32M -49.24M
Net Income
-50.08M -63.37M -53.49M
Selling & General & Admin
24.83M 30.74M 28.53M
Research & Development
14.15M 25.93M 21.8M
Other Expenses
2.51M 31K 206K
Operating Expenses
41.49M 56.68M 50.33M
Interest Expense
5.34M 6.08M 6.59M
Selling & Marketing Expenses
n/a 100K n/a
Cost & Expenses
56.86M 77.81M 71.03M
Income Tax Expense
n/a 1.05M 4.25M
Shares Outstanding (Basic)
2.61M 51K 31.77K
Shares Outstanding (Diluted)
2.61M 51K 31.77K
EPS (Basic)
-19.19 -1.24K -1.68K
EPS (Diluted)
-19.19 -1.24K -1.68K
EBITDA
-43.88M -55.2M -41.13M
EBIT
-44.73M -55.92M -43.66M
Depreciation & Amortization
859K 2.27M 2.54M